OSC-GCDI (P)

OSC-GCDI (P) is a broad-spectrum orally active anti-influenza virus agent that exhibits significant inhibitory effects against both wild-type and Oseltamivir (HY-13317) resistant (H275Y) influenza virus strains in mouse infection models. OSC-GCDI (P) is capable of preventing not only wild-type influenza viruses but also OS-resistant variants with NA (H275Y) [1].

Product Specifications

UNSPSC

12352211

Target

Influenza Virus

Type

Reference compound

Related Pathways

Anti-infection

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/osc-gcdi-p.html

Smiles

O=C(N1/C(C2C(C3=CC=CC=C3C2=O)=O)=N\[C@H]4CC(C(O)=O)=C[C@@H](OC(CC)CC)[C@@H]4NC(C)=O)C5=CC=CC=C5C1=O

Molecular Formula

C32H31N3O8

Molecular Weight

585.60

References & Citations

[1]Jung Y, et al. A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents[J]. ACS Central Science, 2024.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

abx357964 96 Well

Guinea pig Fibroblast Growth Factor 23 (FGF23) ELISA Kit

View Details

MBS1363587-01 0.02 mg (E-Coli)

Recombinant Oryza sativa subsp. japonica Putative 12-oxophytodienoate reductase 6 (OPR6)

View Details

MBS1363587-02 0.02 mg (Yeast)

Recombinant Oryza sativa subsp. japonica Putative 12-oxophytodienoate reductase 6 (OPR6)

View Details

MBS1363587-03 0.1 mg (E-Coli)

Recombinant Oryza sativa subsp. japonica Putative 12-oxophytodienoate reductase 6 (OPR6)

View Details

MBS1363587-04 0.1 mg (Yeast)

Recombinant Oryza sativa subsp. japonica Putative 12-oxophytodienoate reductase 6 (OPR6)

View Details

MBS1363587-05 0.02 mg (Baculovirus)

Recombinant Oryza sativa subsp. japonica Putative 12-oxophytodienoate reductase 6 (OPR6)

View Details